1. Home
  2. CLBK vs MNKD Comparison

CLBK vs MNKD Comparison

Compare CLBK & MNKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Columbia Financial Inc.

CLBK

Columbia Financial Inc.

HOLD

Current Price

$17.17

Market Cap

1.5B

Sector

Finance

ML Signal

HOLD

Logo MannKind Corporation

MNKD

MannKind Corporation

HOLD

Current Price

$5.84

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CLBK
MNKD
Founded
1927
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.7B
IPO Year
N/A
2004

Fundamental Metrics

Financial Performance
Metric
CLBK
MNKD
Price
$17.17
$5.84
Analyst Decision
Hold
Strong Buy
Analyst Count
1
6
Target Price
$17.00
$10.08
AVG Volume (30 Days)
113.3K
2.8M
Earning Date
01-27-2026
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
23.47
EPS
0.15
0.10
Revenue
$202,015,000.00
$313,787,000.00
Revenue This Year
$33.24
$21.54
Revenue Next Year
$12.96
$22.21
P/E Ratio
$117.45
$60.68
Revenue Growth
0.49
17.43
52 Week Low
$12.64
$3.38
52 Week High
$17.44
$7.07

Technical Indicators

Market Signals
Indicator
CLBK
MNKD
Relative Strength Index (RSI) 72.46 60.87
Support Level $16.70 $5.59
Resistance Level $17.40 $6.01
Average True Range (ATR) 0.38 0.19
MACD 0.08 0.05
Stochastic Oscillator 89.50 81.82

Price Performance

Historical Comparison
CLBK
MNKD

About CLBK Columbia Financial Inc.

Columbia Financial Inc is a federally chartered savings bank that serves the financial needs of depositors and the local community as a community-minded, customer service-focused institution. It offers traditional financial services to businesses and consumers. It attracts deposits from the general public and uses those funds to originate a variety of loans, including multifamily and commercial real estate loans, commercial business loans, one-to-four family real estate loans, construction loans, home equity loans and advances, and other consumer loans, and also offers a broad range of insurance products, investment solutions, and wealth management services.

About MNKD MannKind Corporation

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.

Share on Social Networks: